CDC Alerts Nation to Prepare for COVID-19 Vaccine by Early November
CDC has notified officials across all 50 states that limited vaccine doses might be available by late October
COVID19
Phase 3 Trial Investigating COVID-19 Vaccine Candidate AZD1222 Begins
AZD1222 utilizes a replication-deficient chimpanzee adenovirus to deliver a SARS-CoV-2 protein to induce a protective immune response.
SARS-CoV-2 Antibodies for 6 Percent of Frontline Health Care Personnel
Seroprevalence lower for HCP who reported always wearing a face covering while caring for patients.
More Than 20 Percent of Children With COVID-19 Are Asymptomatic
SARS-CoV-2 viral RNA detected for a mean of 14.1 days among children who are asymptomatic.
FDA Could Green-Light COVID-19 Vaccines Before Clinical Trials Completed
Data, not politics, would guide any FDA decision on vaccines, according to agency commissioner
Remdesivir EUA Expanded to Include All Hospitalized COVID-19 Patients
Previously, the EUA limited use to patients with severe COVID-19 disease.
FDA Warns of Hand Sanitizers in Food-Like Packaging
Reports received by the FDA include hand sanitizer sold in a pouch that resembled a snack.
Early Use of Empiric Antibacterial Therapy Common in COVID-19
Likelihood of receiving antibiotics higher for more severe illness, at for-profit hospitals.
MPR Weekly Dose Podcast Episode 49
The ACIP release guidelines for the 2020-2021 vaccination recommendations; In COVID, there’s developments in convalescent plasma authorization, a 15 minute test, and ethnobotanist’s give a stark warning concerning a plant that some are touting as a cure. In other news an intrauterine device gains expanded approval and there’s a label update for hydrochlorothiazide.
Abbott’s 15-Minute COVID-19 Antigen Test Gets Emergency Use Authorization
Results are provided within 15 minutes and can be read directly from the testing card.
